U.S., Sept. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07178327) titled 'Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101' on Sept. 10.
Brief Summary: This is a Phase 1, two-part, first-in-human, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single dose of LYN101 in healthy subjects (part A) and multiple doses in postmenopausal women with low bone mass (part B).
Study Start Date: Sept. 06
Study Type: INTERVENTIONAL
Condition:
Osteoporotic Fracture
Intervention:
DRUG: LYN101
In Part A, participants will receive single dose of LYN...